Immunome Inc

Immunome, Inc. is a biopharmaceutical entity engaged in harnessing the human immune system to cure cancer. The company operates at the global level, with a primary focus on leveraging its proprietary technology to treat a wide range of diseases. Immunome, Inc. operates within the biotechnology sector and aims to generate antibodies against multiple targets. Its significant approach represents a broad attack on cancer, defining its uniqueness in the medical industry. Keep up to date on the latest share price changes by adding IMNM stock to your eToro watchlist.